Dr. Diamandis is using proteomics and mass spectrometry to discover and validate novel biomarkers for diagnosis and monitoring of cancer. He is examining the role of cardiac glycosides and other compounds as novel therapeutics for cancer. He is also investigating novel ways for prenatal diagnosis of Down Syndrome and other fetal abnormalities by using simple tests in maternal blood. Holds the Hold'em for Life Chair in Prostate Cancer Biomarkers. Dr. Diamandis is the Director of the Advanced Center for Detection of Cancer and is working closely with clinicians at the Koffler Center for Urologic Diseases to study prostate cancer and male infertility.
